US Activist Hedge Fund Institutional SEC 13D 13G — October 16, 2026

16-10-2026

Chairman and Director Choo Chee Kong filed an amended Schedule 13D reporting beneficial ownership of 3,003,996 Ordinary Shares of CytoMed Therapeutics Ltd (GDTC), or 25.17% of the 11,934,908 shares outstanding. The filing discloses open-market purchases of 29,250 shares on the Nasdaq Capital Market between October 12 and October 15, 2026 for approximately $25,117.35 (weighted average price of $0.8587), funded with personal funds. The filing does not disclose any sales, and no regulatory action is reported.

• · Filing is a Schedule 13D/A (amendment) with a live event date of October 12, 2026, reported October 16, 2026
• · Reporting person may be deemed a 'group' under Section 13(d)(3) with remaining Glorious Finance shareholders, though no formal agreement exists
• · Company states all transactions complied with the insider trading policy and Rule 10b-5
• · Reporting person states no current plans regarding Item 4(a)-(j) matters beyond board-related discussions
• · Shares from Glorious Finance and EP Capital were issued in exchange for capital contributions; direct holdings were acquired with personal funds

16-10-2026

SV Biotech Crossover Opportunities Fund LP and its general partner SV BCO I GP LLP filed a Schedule 13D reporting beneficial ownership of 1,920,667 shares of TRex Bio, Inc. common stock, representing approximately 7.0% of the 27,445,682 shares outstanding as of October 13, 2026. The stake comprises 957,143 shares bought in the IPO at $14.00 per share (aggregate $13,400,002) and 963,524 shares from conversion of preferred stock at IPO closing. The filing is a passive-investment disclosure with a 180-day lock-up in place.

• · Crossover Fund's IPO purchase was at the $14.00 public offering price, with the GP paying no separate consideration.
• · Registration rights under the Investors' Rights Agreement (dated November 7, 2024) include demand S-1 and S-3 rights, with the Issuer covering registration expenses up to $50,000 for counsel.
• · The lock-up restricts sales, hedging, and registration demands for 180 days without consent of J.P. Morgan and Evercore.
• · The filing states the holding was made for investment purposes and the Reporting Persons may buy or sell shares in the future, which could affect supply once the lock-up expires.

16-10-2026

BVF Partners and affiliated reporting persons filed Amendment No. 4 to Schedule 13D on Olema Pharmaceuticals (OLMA), disclosing aggregate beneficial ownership of 8,939,731 shares (9.8%, including pre-funded warrants subject to a 9.99% blocker). Director Dr. Gorjan Hrustanovic resigned from the Board and its Compensation and Science & Technology Committees effective October 14, 2026, stating no disagreement with the Issuer. No reporting person transacted in the Issuer's securities in the past sixty days.

• · Dr. Hrustanovic's resignation was not the result of any disagreement with the Issuer on any matter relating to its operations, policies or practices
• · Hrustanovic is obligated under an agreement with BVF Partners to transfer economic benefit from sale of his option shares to Partners
• · Stock options were awarded to Dr. Hrustanovic for no consideration in connection with Board service
• · Reporting persons' beneficial ownership percentages are calculated using 87,497,607 shares outstanding per the Q2 2026 Form 10-Q
• · Pre-funded warrants have a $0.0001 exercise price and are exercisable immediately with no expiration

16-10-2026

Ares Management LLC and affiliated Ares entities filed Amendment No. 11 to Schedule 13D reporting that, following the consummation of a merger on October 14, 2026, the Issuer became a wholly owned subsidiary of Parent and each outstanding share of Clear Channel Outdoor Holdings, Inc. (CCO) was converted into the right to receive $2.43 per share in cash. As a result, the Reporting Persons no longer beneficially own any Common Stock and have ceased to be beneficial owners of more than 5% of the class. The Issuer has requested NYSE delisting and intends to deregister the Common Stock under the Exchange Act.

• · Merger Sub merged with and into the Issuer on October 14, 2026, with the Issuer surviving as a wholly owned subsidiary of Parent
• · The Issuer notified the NYSE of completion and requested trading suspension and removal of listing; a Form 25 filing has been requested
• · The Issuer intends to file Form 15 to terminate Section 12(g) registration and suspend Section 13 and 15(d) reporting obligations after the Form 25 becomes effective
• · No transactions in Common Stock by the Reporting Persons or Related Persons were effected in the past 60 days

16-10-2026

Pani Corp., a Liberian holding company wholly owned by Petros Panagiotis Panagiotidis (Chairman and CEO of AI OKTO Corp.), filed a Schedule 13D reporting beneficial ownership of 3,206,185 common shares, or approximately 74.2% of the 4,319,916 shares outstanding. The shares were received on October 8, 2026 through a spin-off distribution from Toro Corp., in which Pani received one AI OKTO share for every eight Toro shares held on the October 1, 2026 record date. The filing also discloses related holdings of 40,000 Series B Preferred Shares (held via Pelagos Holdings Corp., with 100,000 votes each) and 5,000,000 Series A Preferred Shares held by Toro, but these are not counted in the 74.2% figure.

• · Series A Preferred Shares are convertible into Units (two shares each) from the third anniversary of issue, in minimum blocks of 150,000 shares
• · Series B Preferred Shares are not convertible into common shares and are not redeemable by the Issuer
• · Series A Preferred dividends are non-cumulative and senior to common shares and Series B Preferred
• · Filing states Mr. Panagiotidis disclaims beneficial ownership of Pani's shares except to the extent of his pecuniary, voting and dispositive interests
• · Reporting Persons reserve the right to acquire, retain or sell additional shares and to pursue extraordinary corporate transactions

16-10-2026

Integrated Core Strategies (US) LLC, together with Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G/A reporting beneficial ownership of Class A Common Stock of Better Home & Finance Holding Company (BETRW) as of September 30, 2026. Integrated Core Strategies directly holds 581,594 shares (4.4%), while the broader Millennium group reports aggregate beneficial ownership of 591,575 shares (4.5%), with no sole voting or dispositive power and all positions filed as passive under Rule 13d-1(c). The filing is a routine ownership update with no stated intent to influence control of the issuer.

• · Filing made under Rule 13d-1(c), indicating a passive investment position rather than an activist stake
• · Reporting persons certify the securities were not acquired and are not held to change or influence control of the issuer
• · Beneficial ownership percentages calculated per Rule 13d-3(d)(1)(i), presuming exercise of warrants held by reporting persons within 60 days
• · Filing is a joint filing under Rule 13d-1(k) with an executed Joint Filing Agreement dated October 15, 2026
• · Issuer formerly known as Aurora Acquisition Corp. and Aurora Capital Holding Corp., indicating a SPAC-origin company

16-10-2026

Temasek Holdings (Private) Limited filed a Schedule 13G reporting beneficial ownership of 11,873,655 ordinary shares of Pasqal Holding SA (formerly Bleichroeder Acquisition 2 France), representing 5.6% of the 212,293,691 shares outstanding as of September 1, 2026. The holding is passive, filed under Rule 13d-1(d), and held through two indirect wholly-owned subsidiaries, with Temasek reporting sole voting and dispositive power over all shares.

• · Event date of the reportable change is 09/30/2026, with the filing made on October 16, 2026
• · Filing is a LIVE Schedule 13G under Rule 13d-1(d), which applies to passive holders who acquired shares before the issuer's registration under Section 12
• · Temasek reports 0 shares with sole voting power and 11,873,655 with shared voting power and shared dispositive power
• · Issuer's CUSIP is F70289107 and the issuer changed names from Bleichroeder Acquisition 2 France (March 2026) and later Bleichroeder Acquisition France Merger Sub 2 (May 2026) before becoming Pasqal Holding SA

16-10-2026

Capricorn Fund Managers Ltd, a London-based FCA-regulated investment adviser, filed a Schedule 13G reporting beneficial ownership of 13,280,549 Class A ordinary shares of Blend Labs, Inc. (BLND), representing 5.6% of the class as of September 30, 2026. The filing is a passive, Rule 13d-1(b) disclosure made in the ordinary course of business, with sole voting and dispositive power over all reported shares and no shared power.

• · Filing is a Schedule 13G under Rule 13d-1(b), filed by an investment adviser (IA) regulated by the FCA, indicating a passive rather than activist stake.
• · Reporting person certifies the shares were acquired and are held in the ordinary course of business without the purpose or effect of changing or influencing control of the issuer.
• · Event date (position as of) is September 30, 2026; filing submitted October 16, 2026, with status marked LIVE.
• · Blend Labs is a Delaware corporation headquartered in Novato, California, with fiscal year ending December 31.

16-10-2026

David James Donnalley filed a Schedule 13G on October 16, 2026 reporting beneficial ownership of 219,539 Class A units of Belpointe PREP, LLC (OZ), as of October 15, 2026, representing 5.6% of the class (5.55% per the cover-page detail). The filing is made under Rule 13d-1(c) as a passive holder, and the filer certifies the securities were not acquired to change or influence control of the issuer. No change in control or other adverse event is reported.

• · Filing is a LIVE Schedule 13G under Rule 13d-1(c), indicating a passive investor with a stake above 5%
• · Reporting person holds sole voting and sole dispositive power over all 219,539 units; no shared power is reported
• · Event date of October 15, 2026 precedes the October 16, 2026 filing date

16-10-2026

TSP Capital Management Group, LLC filed an amended Schedule 13G reporting beneficial ownership of 1,105,301 shares of Maui Land & Pineapple Co Inc (MLP) common stock as of September 30, 2026, representing approximately 5.57% of the class. The filing is made as an investment adviser under Rule 13d-1(b) and includes a certification that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · Reporting person is a Delaware-organized investment adviser (IA), with business address at 382 Springfield Avenue, Suite 500, Summit, NJ 07901
• · Filing is a LIVE amendment with an event date of September 30, 2026, filed under Rule 13d-1(b) (passive institutional investor, not an activist 13D filing)
• · Filing references a prior Schedule 13G accession number (0001172661-26-002493), indicating this is an update to an existing position disclosure
• · Reported 5.57% ownership is slightly above the 5% threshold requiring Schedule 13G disclosure; Item 4 percent of class (5.55%) differs slightly from the cover page figure (5.57%)
• · Discrepancy noted: the filing's internal figures differ (1,105,301 aggregate vs. 1,102,001 shared-power shares), and percentage figures are not perfectly consistent between sections, which may warrant verification against the original filing

16-10-2026

TSP Capital Management Group, LLC filed a Schedule 13G disclosing beneficial ownership of 1,471,701 shares of Global Water Resources, Inc. (GWRS) common stock, representing 5.11% of the class as of September 30, 2026. The filing is made under Rule 13d-1(b) by an investment adviser (IA) holding the shares in the ordinary course of business, with a certification that the position is not held to influence control of the issuer.

• · Filing is a LIVE Schedule 13G with a reporting date of 09/30/2026, filed October 16, 2026
• · Holder reports sole voting and sole dispositive power over all 1,471,701 shares, with no shared power
• · Filer is a Delaware entity classified as an investment adviser (IA) under Rule 13d-1(b), a passive-investor filing category
• · Subject company is in the Water Supply industry (SIC 4941), headquartered in Phoenix, AZ

16-10-2026

Voss Capital, LP and its affiliated reporting persons (Voss Value Master Fund, Voss Value-Oriented Special Situations Fund, Voss Advisors GP, LLC, and Travis W. Cocke) filed an amended Schedule 13G reporting aggregate beneficial ownership of 3,482,440 shares of Five9, Inc. common stock, or approximately 4.7% of the 74,723,531 shares outstanding as of July 31, 2026. The filing is made under Rule 13d-1(c) as a passive holder and includes a certification that the shares were not acquired for the purpose of influencing control of the issuer. The position is reported as of September 30, 2026.

• · Filing is a Schedule 13G/A amendment under Rule 13d-1(c), indicating a passive investor position rather than an activist 13D filing
• · Previous Schedule 13G was filed August 13, 2025, referenced as the base filing for this amendment
• · Reporting date of ownership is September 30, 2026; the filing was submitted October 16, 2026
• · Voss Capital, LP and Travis W. Cocke report shared voting and dispositive power over 597,440 shares in addition to sole power over 2,885,000 shares

16-10-2026

Pacific Investment Management Co. LLC (PIMCO), filing as beneficial owner, amended its Schedule 13D on FreightCar America, Inc. (RAIL) to report beneficial ownership of 16,815,352 shares of Common Stock, representing 48.8% of the outstanding shares. The amendment discloses an October 14, 2026 agreement between the Issuer and the OC III, OC XXVIII and OCI III LFE stockholder entities under which the Issuer agreed to terminate its stockholder rights plan, refrain from adopting a plan with an Acquiring Person threshold below 20%, and subject certain stockholder transfers to 20%+ acquirers to Board approval.

• · The Replacement 2020, 2021 and 2022 Warrants are exercisable for indeterminate numbers of shares, each approximately 0.01% of Common Stock Deemed Outstanding
• · Amendment No. 10 is the tenth amendment to the Original Schedule 13D first filed August 11, 2021
• · The Agreement's full text is incorporated by reference from Exhibit 10.1 to the Issuer's Form 8-K filed October 15, 2026
• · Share count figures are subject to change because warrant exercise amounts (other than the 2023 Warrant) cannot be known with certainty until exercise

16-10-2026

D. E. Shaw & Co., L.P., D. E. Shaw & Co., L.L.C., and David E. Shaw jointly filed a Schedule 13G on October 16, 2026 reporting beneficial ownership of 5,471,380 shares of Sweetgreen, Inc. Class A Common Stock, representing 5.1% of outstanding shares as of October 8, 2026. The filing is a passive ownership disclosure made under Rule 13d-1(c), with the reporting persons certifying the shares were not acquired to influence control of the issuer.

• · Reporting persons disclaim beneficial ownership of the 5,471,380 shares beyond their pecuniary interest as described in the filing
• · Reporting persons hold shared voting and dispositive power over all 5,471,380 shares; no sole voting or dispositive power is reported
• · Filing is a Schedule 13G under Rule 13d-1(c), indicating a passive investor certification rather than an activist 13D
• · Filing is designated a LIVE filing with event date October 8, 2026, and is signed under joint filing agreement (Exhibit 3)
• · Power of attorney exhibits dated August 1, 2024 authorize Daniel R. Marcus and others to sign on behalf of David E. Shaw

16-10-2026

Yong Sing Goo filed an amended Schedule 13G (SC 13G/A) reporting beneficial ownership of 1,401,114 ordinary shares of TMD Energy Ltd (TMDE), representing 5.946% of the outstanding shares as of September 30, 2026. The holder reports sole voting and dispositive power over all reported shares and no shared power. The filing is a passive ownership disclosure under Rule 13d-1(d) and does not indicate any acquisition or change of control.

• · Filing is a Schedule 13G/A under Rule 13d-1(d), typically applicable to holders who acquired shares before the issuer's registration under Section 12 (passive/exempt investor status).
• · Reported holdings are 1,401,114 shares with zero shared voting or dispositive power, indicating sole control by the reporting person.
• · Ownership percentage is calculated against 23,565,000 shares based on the most recent Form 20-F, which may not reflect subsequent share issuances.
• · Filing references CUSIP G88953107 and lists an event date of 09/30/2026, with the amendment submitted October 16, 2026.

16-10-2026

Jane Street Group, LLC and its subsidiaries (Jane Street Capital, LLC and Jane Street Global Trading, LLC) filed a Schedule 13G on October 16, 2026, disclosing aggregate beneficial ownership of 420,473 shares of Netcapital Inc. common stock (par value $0.001), representing 5.4% of the class, as of October 9, 2026. The filing is made under Rule 13d-1(c) as a passive investor, with the reporting persons certifying the shares were not acquired to influence control of the issuer.

• · Filing type is Schedule 13G under Rule 13d-1(c), indicating a passive investor filing rather than an activist 13D.
• · Event date of change in beneficial ownership is October 9, 2026; the filing was submitted October 16, 2026.
• · Ownership is reported with sole voting and dispositive power for the subsidiaries, with Jane Street Group, LLC reporting shared-level aggregation via its subsidiaries.
• · Issuer principal address is 1 Lincoln Street, Boston, MA; the filer's business address is 250 Vesey Street, New York, NY.
• · The security class is Common Stock, par value $0.001 per share, CUSIP 64113L202.

16-10-2026

LAV Biosciences Fund V, L.P., LAV Fund VI, L.P., LAV Fund VI Opportunities, L.P., and managing partner Yi Shi jointly filed a Schedule 13G reporting an aggregate beneficial ownership of 11,858,655 shares (11.1%) of ADARx Pharmaceuticals, Inc. common stock as of September 30, 2026. The position is held predominantly by LAV Biosciences Fund V (11,243,179 shares, 10.5%), with the remainder held by LAV Fund VI and LAV Fund VI Opportunities (307,738 shares each, 0.3% each). The filing is a passive-investor disclosure made under Rule 13d-1(d), following the company's IPO.

• · Percentages are calculated on 106,801,325 shares outstanding per the IPO Prospectus filed September 28, 2026 (File No. 333-298782), assuming no exercise of the underwriters' option.
• · Filing made under Rule 13d-1(d), indicating the holders acquired shares before the issuer's registration under Section 12, i.e., a passive/exempt investor status.
• · Dr. Shi disclaims beneficial ownership beyond his pecuniary interest, and shares voting and dispositive power as managing partner of the general partners.
• · Reporting Persons are Cayman Islands partnerships with principal business office in Hong Kong; Dr. Shi is a U.S. citizen.

16-10-2026

Shah Capital Management, Shah Capital Fund LLC and Himanshu H. Shah filed Amendment No. 3 to their Schedule 13D on VEON Ltd. (VEON) ADS holdings, reporting aggregate beneficial ownership of 4,620,275 ADS (6.72%) based on 68.8M shares outstanding. The filing is largely a restructuring disclosure: Shah Capital voluntarily withdrew its SEC investment adviser registration via Form ADV-W on October 16, 2026, and the reporting persons state they no longer hold the shares with a purpose of influencing control and intend to report on Schedule 13G going forward. Holdings are reported as unchanged in substance, with ownership now flowing through a newly formed family office structure (Himanshu Shah Family Office LLC).

• · Shah Capital Management withdrew its SEC investment adviser registration effective October 16, 2026, and the reporting persons state they now intend to file on Schedule 13G rather than 13D.
• · The filing states the change in reporting status and restructuring resulted in a material change in the ultimate beneficial ownership structure, even though the reported share counts appear unchanged.
• · Shah Capital Fund LLC was formed and became part of the family office structure; holdings may now be held directly or indirectly through it.
• · Reporting persons state no present plans or proposals that would result in Item 4 actions, other than as described in the filing.

16-10-2026

Shah Capital Management and related reporting persons filed Amendment No. 8 to their Schedule 13D on NOVAVAX INC, disclosing aggregate beneficial ownership of 10,656,964 shares (6.46%) by Himanshu H. Shah, including 10,543,476 shares (6.39%) held through Shah Capital Management and 6,230,000 shares (3.78%) directly held by Shah Capital Fund LLC. The filing reports a sale of 2,870,000 shares by Shah Capital Fund LLC as of October 5, 2026 at an average price of $11.3486, and states that Shah Capital Management withdrew its SEC investment adviser registration on October 16, 2026 in connection with a family office restructuring, with the reporting persons now intending to report on Schedule 13G going forward.

• · Shah Capital Management filed Form ADV-W on October 16, 2026 to voluntarily withdraw its SEC investment adviser registration
• · Reporting persons state they no longer hold shares with a purpose of influencing control and intend to file on Schedule 13G going forward
• · Shah Capital Fund LLC sold 2,870,000 shares as of October 5, 2026, roughly 1.7% of outstanding shares, a material reduction relative to its 6,230,000-share direct position
• · Ownership percentages are calculated against 165 million shares outstanding as of July 31, 2026

16-10-2026

Semiramis Paliou, through Tuscany Shipping Corp. and 4 Sweet Dreams S.A., reports indirect beneficial ownership of 27,858,240 shares of Diana Shipping Inc. (DSX-WT), or 20.35% of outstanding common stock, in Amendment No. 6 to Schedule 13D filed October 16, 2026. The percentage change reflects an increase in the issuer's total outstanding shares to 136,869,100 rather than a change in the reporting persons' holdings, and the filing also discloses warrant exercises on September 11, 2026 that resulted in 5,980,066 common shares being issued.

• · Paliou's 20.35% stake is held indirectly through Tuscany (13.30%) and 4 Sweet Dreams (7.05%), both controlled by Paliou with sole control over voting and disposition; all holdings are reported as shared voting power.
• · The amendment states no change in the reporting persons' holdings; the ownership percentage change is attributed solely to the increase in the issuer's outstanding share count.
• · Warrant exercise on September 11, 2026 of 3,527,501 warrants produced 5,980,066 common shares, a ratio of roughly 1.7 shares per warrant as disclosed.

16-10-2026

Medtronic plc filed Amendment No. 1 to its Schedule 13G to report that it has ceased to beneficially own any shares of MiniMed Group, Inc. (MMED) common stock. The exit followed a split-off exchange offer completed on October 15, 2026, in which Medtronic exchanged MiniMed common stock representing approximately 90% of MiniMed's outstanding shares for Medtronic ordinary shares held by Medtronic shareholders. Medtronic now reports 0 shares (0.0%) and no longer qualifies as a 5%+ holder.

• · Medtronic completed the split-off on October 15, 2026, a day before the filing date.
• · The filing reports 0 shares held by Medtronic, and Medtronic is no longer a Schedule 13G reporting person for MiniMed common stock.
• · Exchange was structured under Rule 13d-1(d), an exempt investor filing basis.
• · MiniMed's common stock is listed under CUSIP 60365F109, and MiniMed's prior entity name was MDT Sub Holdings, Inc. (renamed March 20, 2025).

16-10-2026

Andreas Bovopoulos filed a Schedule 13G/A reporting beneficial ownership of 6,522,905.346 shares of Cosmos Health Inc. (COSM) common stock as of October 16, 2026, representing approximately 6.5% of outstanding shares. The filing is made under Rule 13d-1(c) as a passive investor, with sole voting and dispositive power over the reported shares and a certification that the position is not held to influence control of the issuer. The filing does not disclose any acquisition or disposition price, nor any change in control.

• · Filing made under Rule 13d-1(c), indicating a passive investor certification rather than an active 13D filing
• · Filer certifies the securities were not acquired or held to change or influence control of the issuer
• · Reporting person holds sole voting and sole dispositive power over all reported shares; no shared power reported
• · Filing is a LIVE amendment to a Schedule 13G, reported with a 10/16/2026 signature date

16-10-2026

Maewyn Capital Partners, through Charles Fitzgerald and affiliated funds Maewyn FVR LP and Maewyn FVR II LP, filed Amendment No. 1 to its Schedule 13D on FrontView REIT, Inc. (FVR). On September 30, 2026, Maewyn FVR II LP acquired 80,000 shares of Preferred Stock at $100 per share under an Investment Agreement, funded from working capital. The reporting group now beneficially owns 2,002,887 shares of Common Stock (including 1,058,823 issuable on conversion of 180,000 Preferred shares), representing 7.2% of outstanding Common Stock.

• · Original Schedule 13D was filed April 6, 2026; this is Amendment No. 1 with an event date of September 30, 2026
• · Reporting persons state they have effected no other transactions in Common or Preferred Stock in the past 60 days
• · Filing is a 13D/A amendment; 7.2% exceeds the 5% threshold for Schedule 13D reporting

16-10-2026

Dr. Kenneth Melani and Velocity Fund Partners, LP filed an amended Schedule 13G reporting beneficial ownership of 3,248,741 common shares of Medicus Pharma Ltd. (3.6% of outstanding shares) as of September 30, 2026. This comprises 409,411 shares held directly by Dr. Melani and 2,839,330 shares (3.2%) held by Velocity Fund Partners, LP, which he controls; he disclaims beneficial ownership of the Fund's shares beyond his direct holding. The filing is a passive beneficial ownership disclosure under Rule 13d-1(d) and reports no sale or acquisition narrative.

• · Percentages are calculated on 89,762,721 shares outstanding as of September 10, 2026, per the Company's Schedule 13D filed September 14, 2026
• · Filing is an amendment to a prior Schedule 13G (joint filing agreement originally filed February 13, 2025)
• · Reporting persons' principal business address is listed as Cheswick, PA, while the subject company is in W. Conshohocken, PA

16-10-2026

Glazer Capital, LLC and its Managing Member Paul J. Glazer filed a Schedule 13G reporting beneficial ownership of 4,850,069 shares of Weave Communications, Inc. (WEAV) Common Stock, representing 6.1% of the outstanding class, as of October 9, 2026. The filing is made under Rule 13d-1(c) as a passive investor, with the shares held by Glazer Funds for which Glazer Capital serves as investment manager, and the filers certify the shares are not held to influence control of the issuer.

• · Event date of ownership change is October 9, 2026; filing date is October 16, 2026
• · Filing is a passive investor Schedule 13G under Rule 13d-1(c), not an activist Schedule 13D
• · Reporting persons certify holdings are not for the purpose of changing or influencing control of the issuer

16-10-2026

Equinox Partners Investment Management LLC, together with Equinox Partners, L.P. and Sean M. Fieler, filed Amendment No. 2 to Schedule 13D disclosing beneficial ownership of 805,365 Class A shares of Silvercrest Asset Management Group Inc. (SAMG), approximately 10.3% of the 7,821,782 shares outstanding per the issuer's July 30, 2026 Form 10-Q. The reporting persons' aggregate purchase cost was approximately $8,801,653, and their open-market purchases over the prior 60 days were all buys, with no sales reported. The filing is a stake-building disclosure rather than a change of control, and it does not indicate any plan to seek board representation or other strategic action.

• · Purchases over the past 60 days were executed in open-market transactions at prices ranging from roughly $9.09 to $10.56 per share, with the largest single-day purchase being 108,932 shares on 10/14/2026.
• · Purchases continued through 10/15/2026 (5,692 shares), indicating the accumulation was ongoing up to the filing date.
• · Shares may be held in margin accounts and pledged as collateral, and it may not be possible to determine how much margin was used to buy the Shares.
• · The filing contains no disclosed plans or proposals regarding control, board changes, or strategic transactions (Item 4 not amended).

16-10-2026

EEME Energy SPV I, LLC and its sole member Majique Ladnier filed an amended Schedule 13D reporting beneficial ownership of 228,897,417.60 shares (38.3%) for EEME and 270,564,515.60 shares (45.3%) for Ladnier in XCF Global, Inc. (SAFX), following the October 16, 2026 closing of XCF's acquisition of Southern Energy Renewables, Inc. under the April 13, 2026 Business Combination Agreement, in which EEME received 119,397,858 XCF common shares. The filing also discloses that two EEME-selected directors, Chad J. Langley and John Wharton, joined XCF's Board, and that the acquired shares are subject to a six-month lock-up. The filing does not report a sale or any dilution-neutral trading activity, and its figures are the reporting persons' own disclosures rather than independently verified results.

• · EEME's sole member Majique Ladnier also controls GL Part SPV I and GL Part SPV II, which together with EEME give her beneficial ownership of 45.3% of the class.
• · Reporting persons disclosed the shares were acquired through conversion of $8.4M promissory notes, outright purchases, and an advisory fee, with purchase funds sourced from investor loans to EEME.
• · GL Part SPV II holds a right to acquire up to $99M of additional XCF Class A shares through warrants expiring December 31, 2026.
• · Lock-up requires EEME to refrain from trading BCA-issued shares for six months after closing, limiting near-term sell pressure from this holder.

16-10-2026

Integrated Core Strategies (US) LLC, together with its affiliates Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, filed an amended Schedule 13G reporting beneficial ownership of Braze, Inc. (BRZE) Class A Common Stock as of September 30, 2026. The filing reports 841,311 shares held directly by Integrated Core Strategies (0.7% of the class) and an aggregate 1,547,832 shares (1.4%) potentially beneficially owned by Millennium Management, Millennium Group Management, and Mr. Englander. The filing is a passive-investor disclosure under Rule 13d-1(c) and includes a certification that the securities are not held to influence control of the issuer.

• · Filed as SCHEDULE 13G/A under Rule 13d-1(c), a passive investor designation, with an event date of September 30, 2026
• · Filing is an amendment to a prior Schedule 13G; the Schedule 13G/A was signed October 15, 2026 and filed October 16, 2026
• · Reporting persons hold voting and dispositive power as shared (not sole) with respect to the reported shares
• · Filing includes a Joint Filing Agreement under Rule 13d-1(k) covering all four reporting persons
• · Braze, Inc. is a Delaware-incorporated company (SIC 7372, prepackaged software), formerly named Appboy, Inc., with principal business address in New York, NY

16-10-2026

The B Group, Inc., its subsidiary-level vehicle B Group Capital LLC, and controlling person Branden B. Muhl filed a Schedule 13G reporting beneficial ownership of 833,333 shares of Common Stock of Retension Pharmaceuticals, Inc., representing 10.00% of the company's outstanding shares. The filing is a passive-investor disclosure under Rule 13d-1(c), with a certification that the shares are not held to influence control of the issuer.

• · Event date of the reportable change is October 13, 2026; the filing was made October 16, 2026.
• · The B Group, Inc. acts as investment adviser to B Group Capital LLC; Mr. Muhl is the controlling person of The B Group, Inc. and manager of B Group Capital LLC, so both may be deemed to beneficially own the shares.
• · Reporting persons disclaim status as a 'group' for Schedule 13G purposes and filed a Joint Filing Agreement under Rule 13d-1(k)(1).
• · Filing is a LIVE Schedule 13G under Rule 13d-1(c), a passive-investor filing, with no sole voting or dispositive power reported; all 833,333 shares are reported as shared voting and shared dispositive power.

16-10-2026

JANA Partners Management, LP filed Amendment No. 1 to its Schedule 13D on Alkami Technology, Inc. (ALKT), reporting beneficial ownership of 6,747,707 shares of common stock, or 6.3% of the 106,941,980 shares outstanding as of June 30, 2026. The amendment states that JANA intends to hold discussions with the board and management on profitability, capital allocation and AI partnership opportunities, and reports no transactions in the shares during the past 60 days. The filing contains no period-over-period financial results for the issuer.

• · Amendment No. 1 amends the original Schedule 13D filed June 29, 2026, and reflects the position as of October 14, 2026
• · JANA reports sole voting and dispositive power over all 6,747,707 shares, with no shared power
• · Reporting person is classified as an investment adviser (IA) holding under a limited partnership structure
• · Source of funds is listed as AF (af = funds of the reporting person's investment advisory clients)

16-10-2026

CHS US Investments LLC and affiliated reporting persons filed an amended Schedule 13D disclosing beneficial ownership of 22,479,047 shares of Rent the Runway, Inc. (RENT) Class A Common Stock, representing approximately 62.0% of the outstanding Class A shares. On October 14, 2026, CHS US Investments exercised 19,947,174 subscription rights for 2,495,391 shares at $3.55 per share; no other transactions were effected in the prior 60 days. Including Nexus and Story3 (which the filers disclaim as a group), aggregate reported ownership is approximately 85.5%.

• · The Issuer's 36,269,666 Class A share base combines 33,774,121 shares outstanding as of September 4, 2026 (per 10-Q filed September 11, 2026) with 2,495,545 shares issued October 14, 2026 upon subscription rights exercise
• · Reporting Persons disclaim group status with Nexus and Story3 and disclaim beneficial ownership of their shares
• · APS US Management LLC is investment manager of CHS US Investments; CHS GP LP is managing member; CHS UGP LLC is general partner of CHS GP; CHS UGP is wholly owned by CHS Platform Holdings Pte. Ltd.

16-10-2026

Fund 1 Investments, LLC filed Amendment No. 5 to its Schedule 13D on Funko, Inc. (FNKO), reporting beneficial ownership of 5,527,297 Class A shares, or approximately 9.9% of the 55,995,766 shares outstanding as of August 4, 2026. The filing also discloses cash-settled total return swaps giving economic exposure to 7,287,462 notional shares (about 13.0%) without voting or dispositive power. Recent open-market activity was mixed: net purchases of roughly 50,000 shares between October 1 and October 14, 2026 at $5.63 to $6.47, followed by a sale of 20,116 shares on October 15, 2026 at $6.83.

• · Open-market purchases of 25,000 shares at $5.6263 (Oct 1), 10,000 at $6.0676 (Oct 5), 5,000 at $6.2000 (Oct 7), 5,000 at $6.4737 (Oct 9), and 5,000 at $6.3500 (Oct 14)
• · Sale of 20,116 shares at $6.8326 on October 15, 2026, the only disposition in the reported period
• · The cash-settled swaps give economic results comparable to ownership but confer no voting or dispositive power over the underlying shares
• · Filing is signed October 16, 2026 by Benjamin C. Cable; the reporting person is classified under HC/OO codes

16-10-2026

Qin Zhen, Chairman and CEO of Linkhome Holdings Inc. (LHAI), together with CFO and director Li Na and US Innovation Foundation, filed a Schedule 13D reporting beneficial ownership of 3,820,000 shares of common stock, or approximately 20.143% of the 18,964,500 shares outstanding as of September 24, 2026. The position arose from Qin Zhen's September 24, 2026 gift of 3,820,000 shares to the Foundation, which Qin Zhen and Li Na jointly control; the filing states Qin Zhen no longer holds shares directly. The filing also discloses two earlier private transfers by Qin Zhen of 625,000 shares each on July 31 and August 5, 2026 at $0.80 per share, which reduced his holdings, and states the Reporting Persons have no current plans to change control or operations beyond ordinary officer/director participation.

• · The 3,820,000-share position was transferred by gift without consideration; the Foundation's stated purpose is supporting entrepreneurship among underrepresented ethnic communities and AI entrepreneurship for young people.
• · The Foundation may dispose of some or all shares in the future depending on market conditions, liquidity needs, and charitable objectives; timing and method are not yet determined.
• · Qin Zhen and Li Na are married and share voting and dispositive power over the Foundation's shares, which are held of record by the Foundation.
• · The Reporting Persons have agreed to act together regarding holding, voting, or disposition of the shares and have filed a joint filing agreement (Exhibit 99.1) and a stock donation agreement (Exhibit 99.2).

16-10-2026

MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman filed Amendment No. 2 to their Schedule 13D on Comstock Inc. (LODE), reporting beneficial ownership of 3,959,115 shares, or approximately 5.2% of the 75,993,047 shares outstanding as of July 20, 2026. The filing also discloses open-market sales of 1,000,000 or more shares from September 24 through October 15, 2026, with the largest single sale of 250,000 shares on October 15, 2026 at $1.7983 per share, reflecting a declining stake and a falling share price over the period.

• · Amendment No. 2 amends and restates Items 3, 5(a), 5(c), and 7 of the Schedule 13D originally filed March 25, 2026.
• · Sales in the exhibit total roughly 1.0 million shares over September 24 to October 15, 2026, a material reduction from prior holdings.
• · Sale prices fell from about $2.62 on September 24 to $1.80 on October 15, a decline of roughly 31%, while MAK was selling into the decline.
• · Reporting persons disclaim beneficial ownership of securities they do not directly own, and all transactions were effected in the open market.

16-10-2026

Vereniging Aegon Americas (f/k/a Vereniging Aegon), the largest shareholder of AEGON LTD. (AEFC), filed Amendment No. 15 to its Schedule 13D reporting that the VA Split completed on October 15, 2026, that its 327,885,200 Common Shares B were converted into 8,197,130 Common Shares on a 40-for-1 basis, and that it holds 268,514,288 Common Shares (18.43% of outstanding shares). Under the July and August 2026 share repurchase agreements, the Issuer repurchased 2,995,969 Common Shares from the reporting person for EUR 23,555,197.97 between August 16 and October 15, 2026, against a total committed buyback amount of EUR 63 million. The reporting person's stake percentage was unchanged by the buybacks, as it participated pro rata to maintain its holding near 18.4%.

• · Following the Conversion, the reporting person holds no Common Shares B and its voting power equals its share ownership percentage
• · The 1983 Amended Merger Agreement and Voting Rights Agreement terminated and the Call Option was extinguished effective October 15, 2026
• · Weekly buyback installments were priced between EUR 7.53 and EUR 8.23 per Common Share
• · The Delaware Redomiciliation is subject to conditions and is currently expected to be effective on or about January 1, 2028
• · The July 2026 buyback agreement was expected to complete by December 23, 2026, so remaining buyback installments are still pending

16-10-2026

Fred Faching Chang, through Tekhill USA LLC, Nabal Spring, LLC, and personal holdings including options, reports beneficial ownership of 4,145,400 Newegg Commerce common shares, or 19.8% of the 20,973,423 shares outstanding as of May 26, 2026. Between August 1 and October 12, 2026, Tekhill sold 217,778 shares in open-market NASDAQ transactions at weighted average prices falling from about $15.87 in early September to about $11.30 by October 12, following right of first refusal notices delivered under the shareholders agreement. The filing states no current plans to take other actions listed in Item 4 of Schedule 13D, while reserving the right to sell further holdings.

• · Tekhill sold shares on 31 of 32 trading days in the reported window, with daily volumes mostly 3,582 shares and peak volume of 28,500 shares on 9/17/2026
• · Nabal Spring, LLC and Mr. Chang personally made no transactions during the reported period
• · Schedule 13D/A is Amendment No. 4 per its text, though the document refers to Amendment No. 3 in places, a internal inconsistency
• · Issuer is a British Virgin Islands company listed on NASDAQ Capital Market under symbol NEGG
• · The 13D/A states percentages are computed on 20,973,423 shares outstanding as of May 26, 2026, which predates the reporting period

16-10-2026

Coastlands Capital LP and affiliated reporting persons (including control person Matthew D. Perry) filed a Schedule 13G disclosing beneficial ownership of 500,000 Class A Ordinary Shares of Frazier Life Sciences Acquisition Corp. II, representing 6.41% of the class based on 7,800,000 shares outstanding as of October 15, 2026. The filing is a passive-investor disclosure made under Rule 13d-1(b)/(c), with each reporting person certifying the shares were not acquired to influence control of the issuer.

• · Filing made under Rule 13d-1(b) and Rule 13d-1(c); event date is October 15, 2026, and filing date is October 16, 2026.
• · Reporting persons have sole voting and dispositive power over 0 shares and shared power over 500,000 shares, with no sole or shared power beyond that.
• · Each reporting person disclaims group membership and disclaims beneficial ownership except to the extent of pecuniary interest.
• · Issuer is a blank-check company (SIC 6770) with business address in Palo Alto, CA; filing is an SC 13G (Schedule 13G) under the Securities Exchange Act of 1934.
• · Joint filing agreement (Exhibit 99.1) appoints Coastlands Capital LP as attorney-in-fact for the reporting persons.

16-10-2026

Holcim Ltd. and its subsidiary Inversiones ASPI S.A. filed Amendment No. 2 to Schedule 13D, reporting beneficial ownership of 211,985,547 common shares of Cementos Pacasmayo S.A.A. (approximately 50.01% of the 423,868,449 shares outstanding as of October 15, 2026). The amendment restates the Share Purchase Agreement disclosure: Holcim agreed to launch a public tender offer for at least an additional 24.99% of shares, and on October 14, 2026 the SMV granted an exemption allowing Inversiones to conduct the offer, which will cover any and all outstanding common shares including ADSs. As of the filing date, the Public Tender Offer has not yet been launched.

• · On June 15, 2026, Holcim's Executive Committee determined the tender offer would cover any and all issued and outstanding Common Shares
• · On October 14, 2026, MSRA S.A.C. submitted its valuation report on the Public Tender Offer to the SMV
• · Regulator reference: SMV Oficio No. 5172-2026-SMV/11.1 granted the exemption permitting Inversiones to conduct the offer
• · Inversiones ASPI S.A. has sole voting and dispositive power over the 211,985,547 shares; Holcim reports shared power over the same shares

16-10-2026

Jack Jiajia Huang and affiliated entities filed Amendment No. 11 to Schedule 13D on 51Talk Online Education Group (COE), reporting beneficial ownership of 134,684,684 Class A ordinary shares (37.4% of Class A, per the filing) and 24.7%/20.2% stakes for Dasheng International Holdings and Dasheng Global respectively, with Huang's shares representing 42.4% of total voting power. HH Talent Limited, an entity tied to Huang, continued open-market ADS purchases under a Rule 10b5-1 plan, buying roughly 250,600 ADSs for approximately US$4.4 million between March and September 2026. The filing does not disclose any change in the number of Class B shares held or any sale by the reporting persons.

• · HH Talent Limited trading plan targets purchase of 200,000 ADSs; roughly 250,600 ADSs had been bought as of September 25, 2026, exceeding the plan figure as reported
• · Schedule I shows HH Talent purchases in September 2026 at a weighted average of about US$11.48 to US$11.50 per ADS, with 20,460 ADSs bought on September 25, 2026
• · Filing states Reporting Persons made no other transactions in the ordinary shares in the past 60 days beyond Schedule I purchases
• · Filing reports 7,297,560 Class A shares (ADSs) held by Huang in a note, versus 7,111,380 in the open-market purchase note; the two figures reflect different categories as disclosed

16-10-2026

JPMorgan Chase Bank, National Association filed an amended Schedule 13G (Amendment, filed October 16, 2026) reporting its beneficial ownership in DWS Municipal Income Trust (KTF) as of October 14, 2026, relating to its Variable Rate MuniFund Term Preferred Shares, Series 2020-1. The filing reports 0 shares beneficially owned and 0% of the class, and certifies the holdings were acquired in the ordinary course of business and not for the purpose of influencing control. Routine passive-holder disclosure with no change in control implications.

• · Filing is a SCHEDULE 13G/A under Rule 13d-1(b), a passive-holder filing by a bank.
• · Reporting person is JPMorgan Chase Bank, N.A.; the amendment reflects a disposition to zero reported holdings, not a new stake.
• · Subject class is Variable Rate MuniFund Term Preferred Shares, Series 2020-1 of the trust, CUSIP-referenced as 233368406.

16-10-2026

Pertento Partners LLP, together with affiliates Pertento Advisors LLC, Pertento Master Fund Limited, and managing partner Eduardo Marques, filed a Schedule 13G/A reporting beneficial ownership of 6,140,022 shares of Grocery Outlet Holding Corp. (GO) common stock, equal to 6.2% of the class, as of October 13, 2026. Of this position, 5,077,281 shares (5.1%) are held directly by Pertento Master Fund Limited. The filing is a passive-investor disclosure under Rule 13d-1(c), with a certification that the shares are not held to influence or change control of the issuer.

• · Filing type is Schedule 13G/A (amendment), filed October 16, 2026, under Rule 13d-1(c), indicating a passive investor position.
• · Reporting persons report sole voting and sole dispositive power over the reported shares with no shared power; all shares are held for advisory clients.
• · Only Pertento Master Fund Limited's holding (5.1%) exceeds the 5% threshold on an individual basis; other advisory clients are reported as not individually exceeding 5%.
• · Eduardo Marques is reported as a Brazilian citizen and the filing includes a joint filing agreement (Exhibit A) among all reporting persons.
• · Issuer is headquartered at 5650 Hollis Street, Emeryville, California; CUSIP 39874R101.

16-10-2026

JPMorgan Chase & Co. filed a Schedule 13G/A reporting beneficial ownership of 1,278,125 shares of Andersen Group Inc. (ANDG) Class A common stock, representing 6.9% of the class as of September 30, 2026. The filing reports sole voting power over 1,238,377 shares and sole dispositive power over 1,278,124 shares, with the position held through several JPMorgan subsidiaries under a Rule 13d-1(b) passive-investor filing. This is a routine amendment disclosing a holding in the company's Class A shares rather than an acquisition, control change, or strategic action.

• · Filing is a Schedule 13G/A amendment, filed under Rule 13d-1(b) (qualified institutional investor), with an event date of September 30, 2026
• · Holdings are attributed to JPMorgan Chase & Co. and reported on an aggregate basis across multiple subsidiaries, with the filer certifying the shares were not acquired to influence control of the issuer
• · CUSIP reference 033853102 and issuer address at 333 Bush Street, Suite 1700, San Francisco, CA

16-10-2026

JPMorgan Chase & Co. filed an amended Schedule 13G (LIVE filing) disclosing beneficial ownership of uniQure N.V. ordinary shares as of September 30, 2026. The filing reports aggregate beneficial ownership of 5,951,794 shares, representing 8.5% of the class, with sole voting power over 5,654,307 shares and shared dispositive power over 5,943,150 shares. The filing is made under Rule 13d-1(b) by a bank holding company and is a routine passive-ownership disclosure rather than an activist or control-seeking event.

• · Filing is an amended Schedule 13G (LIVE), filed under Rule 13d-1(b) by a holding company (HC), indicating passive institutional holdings rather than an activist 13D position.
• · Certification states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• · Beneficial ownership is held through subsidiaries including JPMorgan Asset Management (UK) Limited, JPMorgan Chase Bank, N.A., J.P. Morgan Investment Management Inc., and J.P. Morgan Wealth Management Solutions Inc.

16-10-2026

JPMorgan Chase & Co. filed a Schedule 13G/A reporting beneficial ownership of 16,891,995 shares of YUM! Brands, Inc. common stock as of September 30, 2026, representing approximately 6.1% of the class. The filing is a routine amended beneficial ownership disclosure under Rule 13d-1(b) by a bank holding company and does not indicate any change in control intent.

• · Filing is classified under Rule 13d-1(b), indicating a qualified institutional filer that holds the shares in the ordinary course of business without intent to influence control
• · Reporting entity is a holding company (HC) with 15 subsidiary entities contributing to the aggregate position
• · Filing certifies no purpose or effect of changing or influencing control of the issuer